WHO ICTRP trial
Three weeks versus One week radiotherapy regimens in breast cancer patients.
CTRI/2025/02/080216 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/02/080216 |
|---|---|
| Public title | Three weeks versus One week radiotherapy regimens in breast cancer patients. |
| Scientific title | Comparative evaluation of three-weeks versus one week-adjuvant postoperative radiotherapy regimens in breast cancer patients using intensity modulated radiotherapy technique : A randomized controlled study. - NIL |
| Primary sponsor | Dr Sivaranjani |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: C50- Malignant neoplasm of breast |
| Interventions | Intervention1: Arm B: Patients will be given 26Gy in 5 fractions in 1 week. Intervention2: Arm A: Patients will be given 40Gy in 15 fractions in 3 weeks Intervention3: Arm B: Patients will be given 26Gy in 5 fractions in 1 week Control… |
| Registration date | Oct 2, 2025 |
| Target size | 80 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: